Sharing-our-perspective-page-header2



Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • Texas governor signs opioid control legislation

    by
    | Jun 21, 2019
    Tag Icon
    Pain Management, Pharmacy, Government Affairs, Opioids
    A new Texas law to curb opioid abuse includes prescribing restrictions for opioid treatment of acute pain. Effective September 1, 2019, when prescribing for treatment of acute pain, a provider may not prescribe opioids for more than a 10-day supply or refill an opioid.


  • Minnesota enacts opioid prescribing limits

    by
    • Optum for Workers' Compensation
    | Jun 03, 2019
    Tag Icon
    Workers' Compensation, Opioids, Pain Management, Government Affairs, Clinical
    Minnesota has enacted legislation to address the opioid epidemic that includes opioid prescription and dispensing limitations for acute pain and initial prescriptions. The new policy expands upon prior narrower limitations. These new limitations take effect August 1, 2019.


  • Our Industry Trends Report is now available

    by
    • Optum Workers' Comp
    | May 06, 2019
    Tag Icon
    Analytics, Ancillary, Drug Formulary, Medicare Set-Aside, Opioids, Optum Workers Comp Auto No Fault, Predictive Analytics, Settlement Solutions, Workers' Compensation
    A 2018 REVIEW OF THE PREVAILING INDUSTRY INFLUENCES IMPACTING CLAIM OUTCOMES


  • PBM 101: A refresher on the role of pharmacy management in workers’ comp

    by
    • Katie Dwyer - Risk & Insurance
    | Mar 12, 2019
    Tag Icon
    Workers' Compensation, workers compensation, Workers Comp, PBM
    Increasingly, PBMs are relying on massive stores of data to identify broader patterns that inform individual prescription decisions. According to David Young, President and CEO of Optum Workers’ Compensation and Auto No-fault, this is a PBM’s true value proposition.


  • Register for 2019 Continuing Education

    by
    • Optum Workers' Comp
    | Jan 25, 2019
    Tag Icon
    Government Affairs, Webinar - Workers' Compensation, workers compensation, Settlement, Pharmacy, Pain Management, Clinical, Continuing Education
    From the state house, to the pharmacy, to claim resolution, Optum is kicking off its 2019 continuing education calendar with "What to watch for in 2019." See our full year of topics & register to gain the knowledge you need to move move forward this year!


  • FDA approves first non-opioid medication for opioid withdrawal symptoms

    by
    | May 17, 2018
    Tag Icon
    Workers' Compensation, Opioids
    the FDA approved Lucemyra™ (lofexidine hydrochloride) for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.


  • New drug therapy approvals in 2017

    by
    • Optum Workers' Comp
    | Feb 01, 2018
    Tag Icon
    The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has published their annual report, Advancing Health through Innovation: New Drug Approvals and Other Drug Therapy Advances of 2017. This report not only summarizes the approval of 46 new medications in 2017, it also provides information on the CDER’s role in supporting the FDA’s efforts to endorse innovation, efficiently execute the review and approval of new medications while maintaining patient safety, and improve various treatments for patients



Stay informed by receiving latest updates

Do you have a question about a blog post?